The effects of an institutional care map on the admission rates and medical costs in women with acute pyelonephritis

Academic Emergency Medicine

Volumn 15, Issue 4, 2008, Pages 319-323

  Kim, Kyuseok ^a   Lee, Christopher C ^b   Joong, Eui Rhee ^a   Gil, Joon Suh ^a   Lee, Hwi Jae ^a   Hong, Bin Kim ^a   Singer, Adam J ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute pyelonephritis; Women

Indexed keywords

ANTIEMETIC AGENT; ANTIPYRETIC AGENT; CIPROFLOXACIN; KETOROLAC; METOCLOPRAMIDE; PARACETAMOL;

ACUTE PYELONEPHRITIS; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; COST OF ILLNESS; EMERGENCY WARD; FEMALE; FEVER; FLUID THERAPY; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; VOMITING; WOMEN'S HEALTH; ACUTE DISEASE; CHI SQUARE DISTRIBUTION; ECONOMICS; EMERGENCY HEALTH SERVICE; PROSPECTIVE STUDY; PYELONEPHRITIS; STATISTICS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CLINICAL PROTOCOLS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITAL COSTS; HUMANS; PATIENT ADMISSION; PROSPECTIVE STUDIES; PYELONEPHRITIS;

EID: 42949133359     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2008.00070.x     Document Type: Article

References (16)

1. Bergeron MG. Treatment of pyelonephritis in adults. Med Clin North Am. 1995; 79:619-46.
2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002; 113(Supp):1A 5S-13S.
3. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999; 29:745-58.
4. Hooton TM. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am. 2003; 17:303-32.
5. Nicolle LE. Management of acute uncomplicated pyelonephritis. In: Bergan T, ed. Urinary Tract Infections. Infectiology. Vol. 1. Basel: Karger, 1997, pp 8-13.
6. Brown P, Ki M, Forman B. Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics. 2005; 23:1123-42.
7. Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002; 287:2701-10.
8. Tenner SM, Yadven MW, Kimmel PL. Acute pyelonephritis: preventing complications through prompt diagnosis and proper therapy. Postgrad Med. 1992; 91:261-8.
9. Efstathiou SP, Pefanis AV, Tsioulos DI, et al. Acute pyelonephritis in adults: prediction of mortality and failure of treatment. Arch Intern Med. 2003; 163:1206-12.
10. Miller O II, Hemphill RR. Urinary tract infection and pyelonephritis. Emerg Med Clin N Am. 2001; 19:655-74.
11. Israel RS, Lowenstein SR, Marx JA, Koziol-McLain J, Svoboda L, Ranniger S. Management of acute pyelonephritis in an emergency department observation unit. Ann Emerg Med. 1991; 20:253-7.
12. Elkharrat D, Chastnag C, Boudiaf M, Le Corre A, Raskine L, Caulin C. Relevance in the emergency department of a decisional algorithm for outpatient care of women with acute pyelonephritis. Eur J Emerg Med. 1999; 6:15-20.
13. Wark G, Jorden RC, Severance HW. Treatment of pyelonephritis in an observation unit. Ann Emerg Med. 1991; 20:258-61.
14. Ki M, Park T, Choi B, Foxman B. The epidemiology of acute pyelonephritis in South Korea, 1997-1999. Am J Epidemiol. 2004; 160:985-93.
15. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprimsulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA. 2000; 283:1583-90.
16. Talan DA, Naber KG, Palou J, Elkharrat D. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections. Int J Antimicrob Agents. 2004; 1:S54-66.